| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer
1 company
Teleman Dan Benjamin is a Chief Executive Officer at NSRX. Recent filings cover 3 purchases and 0 sales. Those positions are worth an estimated $507K at current prices.
Teleman Dan Benjamin's largest disclosed position is in NSRX as Chief Executive Officer, worth about $507K. Net of sales, the recent Form 4 record there shows accumulation of 24,450 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 17, 2026 | NSRX Nasus Pharma Ltd. | Chief Executive Officer | Buy | 6,550 | $3.10 | $20,305.00 | +4.2% | - | - | |
| Apr 22, 2026 | NSRX Nasus Pharma Ltd. | Chief Executive Officer | Buy | 2,900 | $3.76 | $10,904.00 | +1.9% | -22.1% | - | |
| Mar 31, 2026 | NSRX Nasus Pharma Ltd. | Chief Executive Officer | Buy | 15,000 | $2.04 | $30,600.00 | +240.2% | - | - |